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R E S E A R C H  A R T I C L E
In healthy adults on Earth, the balance between intraocular and intracranial pressures (IOP, ICP) results in a small, pos-teriorly directed gradient across the lamina cribrosa behind 
the eye. Mechanisms that disrupt homeostasis of the IOP or 
ICP will alter the translaminar pressure difference (TLPD) 
and may eventually lead to permanent changes in vision due to 
alterations in the structural morphology of the posterior eye 
globe. For example, glaucoma, the second leading cause of 
blindness worldwide,26 is primarily associated with an increase 
in IOP and thus an increased posterior TLPD, leading to pro-
gressive degeneration of retinal ganglion cells. In addition, ICP 
has also been found to be significantly lower in patients with 
primary open-angle glaucoma and normal-tension glaucoma 
compared to age-matched controls, demonstrating the impor-
tance of taking both ICP and IOP into consideration when 
evaluating pathologies of the optic nerve head.2 On the con-
trary, a decrease in IOP or increase in ICP can lead to swelling 
of the optic disc (papilledema), a pathognomonic sign in idio-
pathic intracranial hypertension (IIH).34
Notably, during 6-mo missions onboard the International 
Space Station (ISS), more than half of astronauts present with 
structural and functional ophthalmic findings termed the 
Visual Impairment and Intracranial Pressure (VIIP) syndrome20 
or Microgravity Ocular Syndrome (MOS).21 The syndrome is 
associated with optic disc swelling, posterior globe flattening, 
optic nerve sheath distension and choroidal folds,16,20 consis-
tent with a reversal of the TLPD in the anterior direction 
(ICP . IOP).36 The etiology of the ocular changes in astronauts 
is currently unknown; however, our working hypothesis is that 
exposure to microgravity results in a change in the hydrostatic 
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 BACKGROUND:  More than half of astronauts develop ophthalmic changes during long-duration spaceflight consistent with an abnor-
mal intraocular and intracranial pressure (IOP, ICP) difference. The aim of our study was to assess IOP and ICP during 
head-down tilt (HDT) and the additive or attenuating effects of 1% CO2 and lower body negative pressure (LBNP).
 METHODS:  In Experiment I, IOP and ICP were measured in nine healthy subjects after 3.5 h HDT in five conditions: -6°, -12°, and -18° 
HDT, -12° with 1% CO2, and -12° with -20 mmHg LBNP. In Experiment II, IOP was measured in 16 healthy subjects after  
5 min tilt at +12°, 0°, -6°, -12°, -18°, and -24°, with and without -40 mmHg LBNP.
 RESULTS:  ICP was only found to increase from supine baseline during -18° HDT (9.2 6 0.9 and 14.4 6 1 mmHg, respectively), 
whereas IOP increased from 15.7 6 0.3 mmHg at 0° to 17.9 6 0.4 mmHg during -12° HDT and from 15.3 6 0.4 mmHg at 
0° to 18.7 6 0.4 mmHg during -18° HDT. The addition of -20 mmHg LBNP or 1% CO2 had no further effects on ICP or IOP. 
However, the use of -40 mmHg LBNP during HDT lowered IOP back to baseline values, except at 224° HDT.
 DISCUSSION:  A small, posterior intraocular-intracranial pressure difference (IOP . ICP) is maintained during HDT, and a sustained or 
further decreased difference may lead to structural changes in the eye in real and simulated microgravity.
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balance between the IOP and ICP, resulting in a decrease in the 
TLPD or even shifting in the anterior direction. In addition, 
ambient carbon dioxide (CO2) levels on the ISS are on average 
10 times higher than on Earth.17 Exposure to elevated ambient 
CO2, a potent vasodilator, may increase intracranial blood vol-
ume via increased cerebral blood flow and, due to the low com-
pliance of the intracranial space, result in an increase in ICP. We 
also hypothesize that the use of lower body negative pressure 
(LBNP) may act as a countermeasure by attenuating the head-
ward fluid shift and decrease ICP and IOP by redistributing 
venous volume to the lower limbs, similarly to the upright posi-
tion on Earth.
Thus, the primary aim of our study was to evaluate ICP and 
IOP during various degrees of head-down tilt (HDT, a ground-
based spaceflight analog). Our secondary aims were to assess 
the interacting effects of increased ambient CO2 or LBNP dur-
ing HDT as exacerbating or attenuating factors on IOP and ICP, 
respectively.
METHODS
The study was performed in the :envihab facility at the Institute 
of Aerospace Medicine, German Aerospace Center in Cologne, 
Germany. Experiment I was designed to evaluate the effects 
of various degrees of cephalad fluid shifting during 3.5 h HDT 
on cerebral and ocular anatomy and physiology, in addition 
to investigating the interacting effects of HDT and 1% CO2 
and -20 mmHg LBNP. Experiment II was performed to inves-
tigate the effects of stronger levels of LBNP (-40 mmHg) for a 
shorter duration time (5 min) and with an extended range of 
tilt angles.
Equipment
ICP was measured with a transcranial Doppler-based noni va-
sive ICP meter (Vittamed, Kaunas, Lithuania), a device that 
measures the balance of blood flow pulsations in the intracra-
nial and extracranial ophthalmic artery during six external 
orbital pressure exposures (4, 8, 12, 16, 20, and 24 mmHg).28 
Two to three ICP measurements were taken at each time point. 
IOP was measured using an Icare Pro rebound tonometer (Icare, 
Helsinki, Finland) with three measurements taken in both eyes 
in a randomized order at each time point. The median value 
was used for statistical analysis. The intraocular-intracranial 
pressure difference was calculated by subtracting the ICP from 
the IOP at each time point. Beat-by-beat mean arterial pressure 
(MAP) and heart rate (HR) were measured with a Finometer 
(Finapres Medical Systems, Amsterdam, The Netherlands) on 
the third phalange of the right hand, leveled to the height of the 
right atrium. Measurements were taken over 10 min, both at 
supine baseline and after 3 h HDT (baseline cardiovascular 
variables have been reported previously).22
All experiments were conducted in accordance with the 
ethical principles stated in the Declaration of Helsinki and 
approved by the local ethical commission of the regional medi-
cal board (Ärztekammer Nordrhein). All subjects underwent a 
medical screening prior to inclusion in the studies and written 
and informed consent was obtained prior to all experiments.
Procedure
The set-up of Experiment I has been previously described.22 
Briefly, nine healthy male subjects (mean age 6 SD: 25 6 2.4 yr; 
mean body mass index 6 SD: 24.1 6 2.4 kg · m22) participated 
in a crossover design experiment with five randomized con-
ditions: -6°, -12°, -18° HDT, -12° HDT with 1% CO2, and -12° 
HDT with -20 mmHg LBNP, with at least 1 wk between each 
condition to prevent carry-over effects. Subject exclusion crite-
ria for participation in the study included smoking, current 
prescription medication use, IOP . 20 mmHg, more than +5 
or -6 diopters, history of abnormal IOP or diseases of the optic 
nerve, any neurological or cardiovascular disease, and history 
of increased ICP. Each experimental day consisted of ICP and 
IOP baseline data collection in the supine (0°) position, fol-
lowed immediately by 5 h total in the HDT position with ICP 
and IOP measurements taken after 3.5 h HDT. Increased ambi-
ent CO2 was administered with a tank and mask system (tank 
composition: 1.07–1.09% CO2, 19.7–19.9% O2, N2 balance). A 
custom designed LBNP was constructed for the -12° HDT posi-
tion and pressure was maintained at -20 mmHg in the LBNP 
chamber throughout the duration of the HDT exposure. Sub-
jects were instructed to consume 40 ml of fluid per kilogram 
body weight and refrain from caffeinated beverages and alcohol 
in the 24 h preceding the experiment. On the experimental day, 
fluid and nutritional intake was standardized for each individ-
ual and kept constant for all five experimental conditions.
Experiment II consisted of 16 healthy subjects (8 male, 
8 female; mean age 6 SD: 26.6 6 3.7 yr; mean body mass 
index 6 SD: 22.7 6 2 kg · m22) that participated in 12 ran-
domized conditions: +12°, 0°, -6°, -12°, -18°, -24° tilt, and +12°, 
0°, -6°, -12°, -18°, and -24° tilt with -40 mmHg LBNP. Subject 
exclusion criteria included smoking, current prescription medi-
cation use, BMI . 26 kg · m22, history of cardiovascular diseases, 
and severe orthostatic intolerance. During the experiment, sub-
jects remained in the supine 0° position for a 30-min baseline 
prior to tilt exposure. Each subsequent condition was main-
tained for 5 min, followed by recovery for 10 min in the supine 
position before proceeding to the next condition. IOP was mea-
sured at baseline (0°), during the last minute of each HDT 
exposure (i.e., min 4), and the last minute of the recovery phase 
in the supine position (i.e., min 9). The experiments were con-
ducted on a custom built, automatic tilt table with an integrated 
LBNP. The LBNP was sealed at the iliac crest of each subject and 
ventilation inside the LBNP chamber was maintained during 
the tilt conditions without LBNP.
Statistical Analysis
All statistical analyses were carried out with R version 3.1.2 
64-bit (http://www.r-project.org). The level for statistical sig-
nificance was set to a 5 0.05 and b was set to 0.2. ANOVA and 
linear mixed effect models with time and condition as main 
effects and subject ID as a random effect were constructed and 
Bonferroni posthoc testing was performed. Eye lateralization 
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was added as a main effect for IOP analysis. Data are presented 
as mean 6 SEM for subjects who completed all conditions of 
the respective study.
RESULTS
ICP measurements during HDT conditions in Experiment I are 
shown in Fig. 1. Significant main effects of time [F(1,146) 5 
29.7, P , 0.001] and condition [F(4,146) 5 7.6, P , 0.001] 
were found, with a significant time-condition interaction 
[F(4,146) 5 6.9, P , 0.001]. Posthoc analysis revealed no 
change in ICP from the baseline (0°) to -6° (P 5 0.9) or -12° 
HDT (P 5 0.4), however, there was an increase in ICP from 
9.2 6 0.9 mmHg at 0° to 14.4 6 1 mmHg during -18° HDT (P 
, 0.001, Fig. 1A). At -12° HDT, there was no further change 
in ICP with the addition of a 1% CO2 atmosphere (P 5 0.7) 
or the addition of -20 mmHg LBNP (P 5 0.6, Fig. 1B).
After 3.5 h HDT (Experiment I), IOP was found to have sig-
nificant main effects of time [(F(1,158) 5 132.2, P , 0.001] and 
condition [F(4,158) 5 10.97, P , 0.001] with a significant time-
condition interaction [F(4,158) 5 7.4, P , 0.001]. Post hoc 
analysis revealed that IOP increased from 15.7 6 0.3 mmHg at 
0° to 17.9 6 0.4 mmHg during -12° HDT (P , 0.001) and from 
15.3 6 0.4 mmHg at 0° to 18.7 6 0.4 mmHg during -18° HDT 
(P , 0.001, Fig. 2A). When comparing the HDT conditions, 
IOP increased from the -6° to -12° HDT (P , 0.001) and fur-
ther from -12° to -18° HDT (P 5 0.02). During -12° HDT with 
the addition of -20 mmHg LBNP, no further change in IOP 
was detected compared to the -12° HDT plus ambient air 
pressure condition (P 5 0.2, Fig. 2B). The addition of 1% CO2 
to -12° HDT resulted in a small decrease in IOP compared 
to -12° HDT plus ambient air (P , 0.001), although IOP was 
still increased compared to baseline (16.4 6 0.4 mmHg vs. 
14.8 6 0.3 mmHg, respectively, P , 0.001, Fig. 2B). The pos-
terior intraocular-intracranial pressure difference at supine 
baseline was maintained during all HDT conditions with no 
significant main effect of time [F(1,67) 5 0.07, P 5 0.8], how-
ever there was a significant main effect of condition [F(4,67) 5 
3.2, P 5 0.02] (Table I).
MAP had a significant main effect of time [F(1,79) 5 34.9, 
P , 0.001] and increased from 73.6 6 2.1 mmHg at 0° to 89.1 6 
4 mmHg during -12° HDT + -20 mmHg LBNP (P , 0.001) and 
Fig. 1. intracranial pressure (icp) before each head-down tilt (HdT) condition 
at 0° baseline (white circles) and after 3.5 h in the HdT position (black circles) 
during (A) various degrees of HdT and (B) with the addition of a 1% co2 envi-
ronment and -20 mmHg lower body negative pressure (LBnp) during -12° HdT. 
data shown as Mean 6 seM, *** P , 0.001
Fig. 2. intraocular pressure (iop) during 0° baseline (white boxes) and after 
3.5 h in the head-down tilt (HdT) position (black boxes) at (A) various degrees 
of HdT and (B) with the addition of a 1% co2 environment and -20 mmHg 
lower body negative pressure (LBnp). data shown as Mean 6 seM, * 5 P , 
0.05, *** P , 0.001
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also from 71 6 2.5 mmHg at 0° to 84.3 6 2.7 mmHg at -18° 
HDT (P , 0.001) (Table II). However, condition was not 
found to be a significant main effect [F(4,79) 5 0.8, P 5 0.6]. 
HR showed a significant main effect of time [F(1,79) 5 9.1, P 5 
0.003] but not condition [F(4,79) 5 1.7, P 5 0.1].
In Experiment II, IOP had significant main effects of both 
time [F(1,767) 5 65.5, P , 0.001] and condition [F(11,767) 5 
17.9, P , 0.001], with a significant time-condition interaction 
[F(11,767) 5 21.7, P , 0.001]. IOP increased from an average 
0° baseline of 14.7 6 0.1 mmHg to 15.7 6 0.4, 16.5 6 0.3, and 
18.4 6 0.4 mmHg during -12°, -18°, and -24° HDT, respectively 
(P 5 0.02, P , 0.001, and P , 0.001) (Fig. 3). The addition of 
-40 mmHg LBNP during HDT was able to attenuate HDT-
induced increases in IOP during -12° and -18° HDT, however at 
-24° HDT, IOP was increased above baseline values (16 6 0.3 
mmHg vs. 14.6 6 0.3 mmHg, respectively P , 0.001). In both 
experiments, there was a trend toward significance for eye lat-
eralization as a main effect [F(1,158) 5 3.6, P 5 0.06, and F(1,767) 
5 5.1, P 5 0.05 for Experiment I and II, respectively].
DISCUSSION
Overall, we found that IOP and ICP increase with steeper HD  
angles, although in a divergent way. Further, IOP always r mained 
higher than ICP, thus maintaining a posterior intraocular-
intracranial pressure difference across all HDT angles. The addi-
tion of a 1% CO2 atmosphere or low level LBNP (-20 mmHg) in 
the -12° HDT position for 3.5 h did not significantly affect IOP 
or ICP compared to HDT alone. However, increases in IOP 
from baseline were attenuated with stronger LBNP (-40 mmHg) 
during short-duration HDT exposure.
On Earth, IIH is characterized by elevated ICP9 resulting 
in a decrease or even reversal of the TLPD in the anterior 
direction accompanied by papilledema due to disruption of 
axonal transport in the optic nerve and subsequent visual 
impairment. Similar ophthalmic findings are also seen in astro-
nauts on long-duration missions aboard the ISS,16,20 prompt-
ing the hypothesis that these changes arise from an anterior 
TLPD due to either an increase in ICP and/or a decrease in 
IOP. However, contrary to IIH which primarily affects obese 
women of child bearing age34, astronauts do not present with 
many of the common IIH symptoms including severe chronic 
headache, pulse synchronous tinnitus, and diplopia. Further-
more, a posterior intraocular-intracranial pressure difference 
was maintained during simulated microgravity (HDT). Taken 
together, the differences between IIH and the VIIP syndrome 
suggest an etiology unique to the microgravity environment 
due to the loss of all hydrostatic gradients. However, the two 
pathologies both present with signs consistent with a lack of 
ICP ‘unloading’ in the upright position due to either an abnor-
mally increased ICP in the upright position (IIH) or a lack of 
upright position all together (VIIP).
In addition, it is important to note that the pressure gradi-
ent across the lamina cribrosa cannot be simplified to only 
equal the difference between IOP and ICP, but rather biome-
chanical and material properties of tissues of the eye and optic 
nerve need to be considered as well. A modeling study by Feola 
et al. found that along with ICP and IOP, optic nerve and lamina 
cribrosa stiffness had significant effects on optic nerve head 
strains.12 Moreover, the thickness of the lamina cribrosa affects 
the translaminar pressure gradient with a thicker lamina cribrosa 
spreading the gradient over a greater distance and reducing the 
shear stress.24 Thus, individual anatomical differences may help 
explain the variance in severity of ocular changes in astronauts, 
as a small increase in ICP and/or decrease in IOP will result 
Table I. The intraocular-intracranial pressure difference at Baseline (0°) and 




-6° 4.7 6 1.4 4 6 1.7
-12° 6.3 6 1.4 7.7 6 1.4
-12° + 1% co2 5 6 1.8 4.7 6 1.7
-12° + -20 mmHg LBnp 6.1 6 1.2 7.4 6 1.5
-18° 6 6 1.8 4.5 6 1.7
data shown as Mean 6 seM; LBnp 5 lower body negative pressure
Table II. Mean Arterial pressure (MAp) and Heart rate (Hr) at Baseline (0°) and 
After 3.5 h Head-down Tilt (HdT) during Various conditions.
MAP (mmHg) HR (bpm)
CONDITION BASELINE HDT BASELINE HDT
-6° 73.2 6 3.6 82.0 6 5.1 61.9 6 3.2 60 6 2.6
-12° 75.3 6 4.1 81.8 6 5.1 65.1 6 2.7 60.6 6 3.2
-12° + 1% co2 76.9 6 4 81.4 6 2.6 60.1 6 3.2 55.7 6 3.1
-12° + -20 mmHg  
 LBnp
73.6 6 2.1 89.1 6 4 *** 61.9 6 3.6 59.4 6 4
-18° 71 6 2.5 84.3 6 2.7 *** 59.8 6 2.9 59 6 2
data shown as Mean 6 seM; LBnp 5 lower body negative pressure; *** P , 0.001
Fig. 3. intraocular pressure (iop) at 0° baseline (white boxes), after 5 min head-
down tilt (HdT, black boxes) and after 5 min HdT with -40 mmHg lower body 
negative pressure (LBnp, gray triangles). data shown as Mean 6 seM, * 5 P , 
0.05, *** P , 0.001
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in an amplified the translaminar pressure gradient across a 
thinner lamina cribrosa.
According to Davson’s equation, ICP is highly dependent 
on the cerebral venous pressure.8,27 In a fully communicating 
venous system, venous pressure is subject to hydrostatic pres-
sure gradients referenced to the hydrostatic indifference point 
(HIP), a point in the venous system where venous pressure is 
unchanged regardless of body position, located at the apex 
of the diaphragm. Petersen et al. found ICP to increase 4.9 and 
9.6 mmHg during -10° and -20° HDT, respectively, in neuro-
surgical patients after 5 min HDT compared to the supine 
baseline.25 In the present study, ICP was found to increase 
about 5 mmHg during 3.5 h exposure to -18° HDT compared 
to the supine baseline, a smaller increase than predicted by 
hydrostatic pressure from the HIP alone. However, the nonin-
vasive TCD-based ICP measurement may underestimate ICP 
compared to invasive measurements, especially at higher ICP 
levels.15 Additional validation studies have found the TCD-
based noninvasive ICP meter to have good correlation with 
invasive ICP measures,28 with a mean difference between paired 
measures of about 4.5 mmHg.3 Therefore, it is possible that in 
the present study, ICP was slightly elevated in the -6° and -12° 
HDT positions but was too small to be detected by noninvasive 
measures.
On the contrary, all hydrostatic gradients are abolished in 
real microgravity and a headward fluid shift of approximately 
1–2 l occurs with notable facial puffiness14 and decreased leg 
volume.23 This fluid shift may lead to decreased cerebral venous 
outflow and increased cerebral venous pressure, potentially 
exacerbated by anatomical compression of the internal jugu-
lar veins which may not occur during HDT.35 A recent para-
bolic flight study involving patients with existing access to 
the CSF space via Ommaya reservoir found ICP to increase 
during the microgravity portion of the flight compared to the 
seated upright position (13 vs. 4 mmHg, respectively), although 
decrease compared to the supine position (15 mmHg).18 Dur-
ing a 9-d spaceflight, ICP was measured directly in a primate 
onboard the Russian biosatellite Cosmos-2229, and was found 
to increase initially by 25–30% compared to seated baseline 
preflight, and decreased over the second half of the mission 
close to baseline values, although still slightly elevated.33 How-
ever, central venous pressure measured in humans in the first 
hours of microgravity exposure, did not increase but rather 
decreased below seated baseline values, likely due to gravita-
tional unloading and subsequent expansion of the thorax.6 
On Earth, the large, and likely gravity dependent change in 
ICP when going from the upright position to supine (about 
12–13 mmHg,25,27) is much greater than the change in IOP 
(about 2–3 mmHg,1,19), demonstrating that a large TLPD (;20 
mmHg11) exists two-thirds of the day when a person is upright 
whereas during sleep, the TLPD is greatly reduced (although 
still in the posterior direction). In microgravity, however, the 
loss of all hydrostatic pressure gradients may result in a con-
stant difference between IOP and ICP over 24 h, hypothesized 
to be similar to the corresponding pressure difference in 
the supine or HDT position on Earth (;5-7 mmHg), resulting 
in a reduction of the TLPD and possibly shifting to the 
anterior direction. Further investigation of gravity and pos-
ture-dependence of both ICP and IOP should be performed 
when considering the etiology of the vision changes during 
spaceflight.
According to the Goldmann equation,5 IOP is dependent on 
the episcleral venous pressure (EVP), as any rise in EVP will 
increase the resistance to aqueous humor outflow. When going 
from the seated to supine position, EVP increases by about 
1 mmHg,30 and is hypothesized to increase further during 
HDT due to increased cerebral venous pressure. Combined 
with engorgement of the choroid, IOP increases with progres-
sive HDT angles as demonstrated. A number of studies have 
demonstrated that IOP increases immediately upon exposure 
to both real and simulated microgravity.31 However, sustained 
bed rest studies have shown variable results. Chiquet et al.7 
found that after 5 - 6 d of -6° HDT bed rest, IOP normalizes or 
even goes below supine baseline values, whereas Taibbi et al.32 
found a ;2 mmHg increase in IOP after 10 d of -6° HDT bed 
rest. In space, evidence suggests that IOP returns to baseline 
values within the first week of microgravity exposure.10,29 It is 
therefore possible that an abnormally low baseline IOP may be 
a factor in the development of ophthalmic abnormalities in 
space due to a lower baseline TLPD. It is also interesting to note 
that structural ophthalmic changes in astronauts appear to 
affect the right eye more than the left,20 whereas asymmetric 
papilledema in patients with IIH on Earth is fairly uncommon.4 
The present study found a trend toward a difference in IOP 
between the left and right eye and further studies are warranted 
to elucidate the potential pathophysiologic role of bilateral vari-
ations in IOP, the bony optic canal and the vascular system in 
the VIIP syndrome.
The addition of increased ambient CO2 during HDT bed 
rest represents a more realistic analog of the ISS environment as 
the partial pressure of CO2 on the space station ranges from 
2.3 to 5.3 mmHg (0.1–0.8%) compared to the normal 
0.3 mmHg (0.04%) on Earth.17 In the present study, we found 
IOP to decrease slightly during -12° HDT plus 1% CO2 com-
pared to -12° HDT alone, however, the absolute increases from 
their respective baselines were similar (1.8 and 2.2 mmHg, 
respectively). Furthermore, the added 1% CO2 environment 
had no detectable effects on ICP during HDT, although was 
shown previously to alter cerebral hemodynamics.22 The lack of 
effects seen on ICP and IOP may be due to the relatively low 
CO2 exposure level in the present study and therefore only a 
very small increase in end tidal CO2.22
While increased ambient CO2 was hypothesized to be a neg-
ative influencing factor, LBNP was tested as a potential counter-
measure to HDT cephalad fluid shifting. Normally, LBNP is 
implemented as a tool to evoke an orthostatic challenge, for 
instance to study orthostatic intolerance, and the majority of 
research studies performed with LBNP are done at levels 
between -40 and -50 mmHg.13 In the present study, -40 mmHg 
LBNP was able to attenuate HDT-induced increases in IOP up 
to -18° HDT, likely by counteracting the HDT-induced cephalad 
fluid shift and redistributing venous blood to the lower limbs. 
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In order to determine the feasibility of implementing LBNP for 
use as a potential countermeasure, we implemented low level 
(-20 mmHg) LBNP during -12° HDT for 5 h total. At this 
LBNP level, subjects were able to tolerate the countermea-
sure with reasonable comfort, although IOP remained 
increased from the supine baseline after 3.5 h. However, Macias 
et al. demonstrated that during -15° HDT, 10-min exposure 
to -25 mmHg LBNP normalized IOP to supine baseline val-
ues, although still elevated compare to seated baseline levels.19 
Therefore, low level LBNP (-20 mmHg) may not be able to 
sustain changes in IOP over longer-duration exposure. Fur-
thermore, -40 mmHg LBNP was found to significantly reduce 
IOP during HDT, however, further studies are warranted to 
determine the effects of strong LBNP on ICP and the TLPD.
There are several limitations inherent to the presented stud-
ies. First, the performed studies demonstrate a simulation of 
spaceflight, however, in an Earth-based model such as bed 
rest, a Gz gravitational gradient still exists which is not present 
in space and therefore, extrapolation of findings from HDT 
to real microgravity warrant caution. In addition, the base-
line measurements were taken in supine position; however, as 
humans spend approximately two-thirds of their day in the 
upright position, it would be useful for future studies to com-
pare interventions to both upright and supine postures. Fur-
thermore, additional studies are necessary to determine the 
long-duration effects of real and simulated microgravity on both 
ICP and IOP, as ocular changes in astronauts are not an immedi-
ate effect of spaceflight but rather arise after weeks or months 
living in microgravity. It is, therefore, likely that the ophthalmic 
changes in astronauts occur after an acclimatization of the 
human body to the microgravity environment and soft tissue 
remodeling due to newly developed tissue stresses and strains.
Overall, this study is the first to report changes in both IOP 
and ICP during exposure to various degrees of HDT. The results 
of this ground-based spaceflight analog study demonstrate that 
a small, yet sustained posterior intraocular-intracranial pres-
sure difference is maintained during HDT, and is not altered in 
the presence of increased ambient CO2. The lack of a larger 
intraocular-intracranial pressure difference during HDT, nor-
mally present in the upright position on Earth, may be respon-
sible for the structural and functional ophthalmic changes seen 
in association with the VIIP syndrome due to a lack of diurnal 
posture-dependent changes in the TLPD. Furthermore, long 
exposure to -20 mmHg LBNP has no effects on ICP or IOP, 
however -40 mmHg LBNP for short durations was able to 
attenuate HDT-induced increases in IOP. Further studies are 
warranted to determine the effects of higher level LBNP on ICP 
and feasible pressure levels to have positive effects yet remain 
operationally feasible.
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